Last edition
News about "evolocumab biosimilar"
Sandoz and Henlius Partner on up to 10 Biosimilars
Sandoz partners with Henlius on up to 10 biosimilars, expanding its pipeline to 39 assets with potential to reach 46, including cetuximab, evolocumab and belimumab.
Evolocumab Biosimilar | 19/08/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members